Sonia’s testimonial after treatment with bilateral guided neurolytic ablations

Morton's neuroma non-surgical treatment, Morton's neuroma treatment, testimonial

Sonia’s Testimonial:

Sonia is from Texas and had bilateral Ultrasound Guided Neurolytic Injections. Sonia suffered from Morton’s neuroma for many years and couldn’t even function at her work. Only 3 weeks her initial treatment, her coworkers are now commenting on her walking ability at work.

This is a short except from her testimonial:

To see Sonia’s full video testimonial (5 min:05 sec) CLICK HERE

Sonia: Just go. Don’t hesitate. It’s so worth the time, effort, and money to do it. Don’t just live with the pain, you can get rid of it. I’m just so thankful. I can feel everything loosening up again. My gait is returning back to normal. It’s just been better and better every day for the past three weeks. I’m not like this athlete or anything like that, but just looking forward to just walking my dogs like I used to.

Janet D. Pearl, MD, MSc is the Medical Director of The Center for Morton’s Neuroma and Complete Spine and Pain Care, an interventional and integrated Pain Management program located in Framingham, Massachusetts. Previously, Dr. Pearl was the Co-Director of the Pain Management Center at St. Elizabeth’s Medical Center, where she was also the Director of the Fellowship program. She is the former Director of a satellite pain center of the Brigham and Women’s Hospital, Pain Management Center, located at the HealthSouth Braintree Rehabilitation Hospital. Dr. Pearl held academic appointments at Harvard Medical School and Tufts Medical School. She serves on the Health Care Services Board of the Commonwealth of Massachusetts Department of Industrial Accidents since 2000 as one of its physician representatives and is Chair of the Committee on Pain Management.

Pin It on Pinterest

phone mortons neruoma
email mortons


 Let’s Talk!

We’re here to help you with any questions you may have. Please don’t hesitate to reach out to us.

  • This field is for validation purposes and should be left unchanged.